can't lose weight on semaglutide Why Am I Not Losing Semaglutide? Explained Half of Patients Stop Semaglutide

In doing so, we consider, among other things, your medical history, any existing conditions, and your medication use

Reducing these while increasing whole-food intake aligns with evidence from the SMILES trial

Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care

GPS has the potential to influence the secretion of adipokines, including adiponectin and resistin, which are critical regulators of insulin sensitivity

A healthcare provider can assess your individual health needs and risks